← Open Payments lookup

BEATRICE PEKU: Open Payments

NPI 1285043851 · CHESHIRE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,451 in 24 payments from 11 companies in 2025. Trend: 2023 $2,055 · 2024 $1,137 · 2025 $2,451

Food & beverage: $2,451
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.6$526
Axsome Therapeutics, Inc.4$483
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$269
Otsuka America Pharmaceutical, Inc.2$246
Alkermes, Inc.2$243
Luye Pharma (USA) Ltd.2$139
ABBVIE INC.1$125
E.R. Squibb & Sons, L.L.C.1$125
Indivior Inc.1$122
Neurocrine BioSciences, Inc.1$111

Products named: Auvelity, CAPLYTA, AUSTEDO XR, UZEDY, ERZOFRI EXTENDED-RELEASE, REXULTI, VRAYLAR, COBENFY.

Industry payments across CT — which companies pay providers there.